| LXR/ApoE activation restricts innate immune suppression in cancer MF Tavazoie, I Pollack, R Tanqueco, BN Ostendorf, BS Reis, ... Cell 172 (4), 825-840. e18, 2018 | 372 | 2018 |
| Tumoural activation of TLR3–SLIT2 axis in endothelium drives metastasis B Tavora, T Mederer, KJ Wessel, S Ruffing, M Sadjadi, M Missmahl, ... Nature 586 (7828), 299-304, 2020 | 98 | 2020 |
| Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells XG Zhu, A Chudnovskiy, L Baudrier, B Prizer, Y Liu, BN Ostendorf, ... Cell metabolism 33 (1), 211-221. e6, 2021 | 73 | 2021 |
| Common germline variants of the human APOE gene modulate melanoma progression and survival BN Ostendorf, J Bilanovic, N Adaku, KN Tafreshian, B Tavora, ... Nature Medicine 26 (7), 1048-1053, 2020 | 60 | 2020 |
| Common human genetic variants of APOE impact murine COVID-19 mortality BN Ostendorf, MA Patel, J Bilanovic, HH Hoffmann, SE Carrasco, ... Nature 611 (7935), 346-351, 2022 | 34 | 2022 |
| Myeloid-derived suppressor cells in human peripheral blood: optimized quantification in healthy donors and patients with metastatic renal cell carcinoma A Flörcken, A Takvorian, A Singh, A Gerhardt, BN Ostendorf, B Dörken, ... Immunology letters 168 (2), 260-267, 2015 | 28 | 2015 |
| Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes BN Ostendorf, E Flenner, A Flörcken, J Westermann PLoS One 13 (5), e0197823, 2018 | 24 | 2018 |
| Nilotinib BN Ostendorf, P le Coutre, TD Kim, A Quintás-Cardama Small Molecules in Oncology, 67-80, 2014 | 20 | 2014 |
| Association between low uric acid levels and acute graft-versus-host disease BN Ostendorf, O Blau, L Uharek, IW Blau, O Penack Annals of hematology 94, 139-144, 2015 | 16 | 2015 |
| A novel domain regulating degradation of the glomerular slit diaphragm protein podocin in cell culture systems M Gödel, BN Ostendorf, J Baumer, K Weber, TB Huber PLoS One 8 (2), e57078, 2013 | 14 | 2013 |
| Autophagy suppresses breast cancer metastasis BN Ostendorf, SF Tavazoie Developmental Cell 52 (5), 542-544, 2020 | 12 | 2020 |
| Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation BN Ostendorf, TH Terwey, PG Hemmati, D Böhmer, U Pleyer, R Arnold European Journal of Haematology 95 (1), 90-92, 2015 | 10 | 2015 |
| Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization RH Moy, A Nguyen, JM Loo, N Yamaguchi, CM Kajba, B Santhanam, ... Developmental cell 57 (9), 1146-1159. e7, 2022 | 5 | 2022 |
| Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case report BN Ostendorf, CF Jehn, LG Vuong, H Nogai, PG Hemmati, B Gebauer, ... SpringerPlus 3, 1-5, 2014 | 5 | 2014 |
| LXR agonism depletes MDSCs to promote antitumor immunity MF Tavazoie, I Pollack, R Tanqueco, BN Ostendorf, BS Reis, ... Cancer Discov 8 (3), 263, 2018 | 4 | 2018 |
| BCR-ABL Mutation-Guided Therapy for CML Blast Crisis: A Case Report BN Ostendorf, H Nogai, CD Baldus, T Burmeister, R Arnold Biomarker insights 10, BMI. S22279, 2015 | 3 | 2015 |
| Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis N Adaku, BN Ostendorf, W Mei, SF Tavazoie Cancer research 83 (18), 3013-3025, 2023 | 2* | 2023 |
| Flow-cytometric immunophenotyping in clinical diagnostics BN Ostendorf, L Hansmann, WD Ludwig, B Doerken, R Ratei, ... Deutsche Medizinische Wochenschrift (1946) 141 (21), 1569-1574, 2016 | 2 | 2016 |
| Apoe genotyping in cancer prognostics and treatment S Tavazoie, BN Ostendorf, M Tavazoie, F Gonsalves US Patent App. 17/434,359, 2022 | 1 | 2022 |
| Human Staphylococcus intermedius infection in a patient with postradiation changes BN Ostendorf, RL Oehler, JN Greene Infectious Diseases in Clinical Practice 19 (6), 426-427, 2011 | 1 | 2011 |
Daniel MucidaLaboratory of Mucosal Immunology, Howard Hughes Medical Institute, The Rockefeller UniversityVerified email at rockefeller.edu
